A jury began deliberating Friday morning on whether Abbott Laboratories should pay GlaxoSmithKline hundreds of millions of dollars over allegations of unfair HIV drug pricing. Get the full story »
Inside these posts: AIDS
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Glaxo: Abbott has illegal monopoly in AIDS drugs
From Bloomberg News | GlaxoSmithKline Plc lawyers, in a trial seeking at least $1.5 billion in damages, told jurors that Abbott Laboratories had an illegal monopoly over HIV drugs. Get the full story>>
India rejects Abbott patent of Kaletra AIDS drug
Abbott Laboratories was refused copyright protection on its AIDS drug Kaletra by India’s patent office, allowing Cipla Ltd. and other generic-drug companies to continue selling copies. Get the full story »
FDA approves Abbott HIV test
Abbott Labs said the FDA today approved its new diagnostic test that allows for earlier detection of HIV. Get the full story »
